Adicet Bio Inc. sell dimontalban
Start price
20.08.23
/
50%
€1.64
Target price
20.08.24
€0.000
Performance (%)
7.27%
End price
03.09.23
€1.76
Summary
This prediction ended on 03.09.23 with a price of €1.76. With a performance of 7.27%, the SELL prediction by dimontalban for Adicet Bio Inc. was trending in the wrong direction dimontalban has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Adicet Bio Inc. | 3.365% | 3.365% | 3.490% |
iShares Core DAX® | -1.114% | 3.430% | 25.966% |
iShares Nasdaq 100 | 1.816% | 6.911% | 30.390% |
iShares Nikkei 225® | 2.113% | 5.501% | 23.404% |
iShares S&P 500 | 2.038% | 5.327% | 30.881% |
According to dimontalban what are the pros and cons of Adicet Bio Inc. for the foreseeable future?
Pros
Standard Investments for future growth
Capable Management
Good culture
Sustainability is very important
Stable Large shareholder and/or long term investor
Known brand
Innovative
Cons
High risks for its business
Business model of the past or high risk
Probably not worthwhile Investment
Revenue decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Bad rating
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
Few uniques
Dependend from some customers or products
Growths much slower than the competition
Below average Marketposition
EBIT decline/stagnation expected
negative Cash Flow expected
Risky balance sheet
Very high cyclical dependencies
Comments by dimontalban for this prediction
In the thread Restorbio Inc. diskutieren
Sell mit Kursziel 0,0
In the thread Trading Restorbio Inc.
Sell beendet